Richard Chin, President and CEO at Kindred Biosciences, Inc. (KIN), sold 40,000 shares at $13.28 ($531K) on 2018-10-01, disclosed to the SEC on 2018-10-03.
Open-market sale of $531k KIN by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KIN | SELL | 2021-06-17 | $367K | — | Filing → |
| KIN | SELL | 2019-01-04 | $423K | — | Filing → |
| KIN | SELL | 2018-12-04 | $531K | — | Filing → |